[E-Daily Reporter Kim Kyung-eun ] Concerns over a slowdown in the semiconductor sector weighed on stock prices, pushing the KOSPI down to the 4,800 level. Korea’s leading semiconductor stocks— SamsungElectronics(005930)and SK hynix(000660)—both plunged by more than 6%. However, analysts in the securities industry argue that actual memory prices and demand for artificial intelligence (AI) semiconductors remain robust, suggesting that the recent stock price decline is excessive.
An employee works in the trading room at Hana Bank’s headquarters in Jung-gu, Seoul, on the 20th. (Photo = Yonhap News)
According to MP Doctor on the 20th, as of 1:26 p.m., SamsungElectronics was trading at 183,900 won, down 6.60% from the previous trading day. SK hynix was trading at 1,106,000 won, down 6.51%. As both stocks plummeted in tandem, the KOSPI also retreated to the 4,800 level.
Analysts in the securities industry suggest that the disconnect between stock prices and industry conditions has widened. This is attributed to the continued upward trend in memory semiconductor prices, coupled with the fact that demand for AI infrastructure investment has not shown any significant signs of slowing down.
Kim Young-geon, an analyst at MIRAE ASSET SECURITIES, stated in a report released today, “The stock market is reacting excessively compared to the stable industry conditions.” He added, “If investors avoid these stocks solely out of fear, they will miss out on the robust industry conditions and fundamentals,” and maintained his “overweight” rating on SamsungElectronics and SK hynix.
According to MIRAE ASSET SECURITIES, the current stock prices of SamsungElectronics and SK hynix stand at 1.2x and 1.3x, respectively, based on the 12-month forward price-to-book (P/B) ratio. The report explains that this valuation is comparable to levels seen before the full-scale adoption of AI, when return on equity (ROE) was in the 10% range. In contrast, the average ROE for both companies is projected to exceed at least 50% over the next three years.
The basis for this assessment can be seen in the memory semiconductor spot market. According to the report, while the price of DDR4 16Gb products has fallen 15% from its peak last September, the price of DDR5 16Gb products stands at $60.7, maintaining a decline of less than 1.5% from its recent peak. Spot prices for DDR4 and DDR5 are 44% and 21% higher than contract prices, respectively.
There are also no clear signs of slowing demand in the AI semiconductor market. The hourly rental price for the NVIDIA B300 is fluctuating at a level slightly below its October peak. The hourly rental rates for the B300, B200, and H100 are $7.2, $6.2, and $2.9, respectively—up 58%, 59%, and 35% year-over-year.
Researcher Kim emphasized, “The slowdown in business conditions as perceived by the industry remains limited,” adding, “While there appear to be cases where memory supply contracts have been deferred due to procurement restrictions on graphics processing units (GPUs) by some Greater China customers, tight supply and demand conditions persist, as evidenced by top-tier customers extending their long-term supply agreements (LTAs) to exceptionally long terms.”
The expansion of investments by Anthropic, an AI cloud company that recently raised funds through an IPO, is also cited as a factor supporting semiconductor demand. Analyst Kim noted, “Anthropic stated in its S-1 registration statement that it has already met the automation threshold for research and development,” and analyzed that “cost reductions resulting from automation could accelerate the adoption and widespread use of AI.” He further predicted, “If usage growth continues to outpace efficiency improvements, this IPO could serve as a catalyst for strengthening the medium- to long-term demand base for memory semiconductors.”
As the prolonged period of high interest rates increases the refinancing burden on companies, warning signs of credit rating downgrades have emerged, particularly in sectors experiencing sluggish busi…
In this year’s fall/winter (FW) footwear market, products that combine warmth and style are gaining attention. The selection of sheepskin boots has expanded, ranging from short styles that cover the a…
#Aimed Bio Inc.’s antibody-drug conjugate (ADC) “BHV-1530 (AMB302),” which was licensed to U.S.-based Biohaven, has demonstrated initial anticancer efficacy in a Phase 1 clinical trial. Biohaven plans…